These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33872408)

  • 1. Pharmacological Activation of Nrf2 Enhances Functional Liver Regeneration.
    Chan BKY; Elmasry M; Forootan SS; Russomanno G; Bunday TM; Zhang F; Brillant N; Starkey Lewis PJ; Aird R; Ricci E; Andrews TD; Sison-Young RL; Schofield AL; Fang Y; Lister A; Sharkey JW; Poptani H; Kitteringham NR; Forbes SJ; Malik HZ; Fenwick SW; Park BK; Goldring CE; Copple IM
    Hepatology; 2021 Aug; 74(2):973-986. PubMed ID: 33872408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
    Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
    J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Point Mutation at C151 of
    Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
    Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 is essential for timely M phase entry of replicating hepatocytes during liver regeneration.
    Zou Y; Hu M; Lee J; Nambiar SM; Garcia V; Bao Q; Chan JY; Dai G
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G262-8. PubMed ID: 25524062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bardoxolone methyl prevents metabolic dysfunction-associated steatohepatitis by inhibiting macrophage infiltration.
    Onuma K; Watanabe K; Isayama K; Ogi S; Tokunaga Y; Mizukami Y
    Br J Pharmacol; 2024 Aug; 181(15):2545-2565. PubMed ID: 38599607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.
    Reisman SA; Buckley DB; Tanaka Y; Klaassen CD
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):109-14. PubMed ID: 19371629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bardoxolone methyl modulates efflux transporter and detoxifying enzyme expression in cisplatin-induced kidney cell injury.
    Atilano-Roque A; Aleksunes LM; Joy MS
    Toxicol Lett; 2016 Sep; 259():52-59. PubMed ID: 27480280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
    Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X
    Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.
    Noel S; Zheng L; Navas-Acien A; Fuchs RJ
    Shock; 2014 Nov; 42(5):392-9. PubMed ID: 25105464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-E2-related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice.
    Shirasaki K; Taguchi K; Unno M; Motohashi H; Yamamoto M
    Hepatology; 2014 Jun; 59(6):2371-82. PubMed ID: 24443206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 is involved in maintaining hepatocyte identity during liver regeneration.
    Zou Y; Lee J; Nambiar SM; Hu M; Rui W; Bao Q; Chan JY; Dai G
    PLoS One; 2014; 9(9):e107423. PubMed ID: 25222179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of antioxidant response element activity during liver regeneration after partial hepatectomy.
    Alizai PH; Bertram L; Fragoulis A; Wruck CJ; Kroy DC; Klinge U; Neumann UP; Schmeding M
    J Surg Res; 2016 Dec; 206(2):525-535. PubMed ID: 27884351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
    Yates MS; Tran QT; Dolan PM; Osburn WO; Shin S; McCulloch CC; Silkworth JB; Taguchi K; Yamamoto M; Williams CR; Liby KT; Sporn MB; Sutter TR; Kensler TW
    Carcinogenesis; 2009 Jun; 30(6):1024-31. PubMed ID: 19386581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.
    Tian C; Gao L; Zhang A; Hackfort BT; Zucker IH
    J Pharmacol Exp Ther; 2019 Dec; 371(3):642-651. PubMed ID: 31601682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.
    Aleksunes LM; Goedken MJ; Rockwell CE; Thomale J; Manautou JE; Klaassen CD
    J Pharmacol Exp Ther; 2010 Oct; 335(1):2-12. PubMed ID: 20605904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
    To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
    Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease.
    Aminzadeh MA; Reisman SA; Vaziri ND; Shelkovnikov S; Farzaneh SH; Khazaeli M; Meyer CJ
    Redox Biol; 2013; 1(1):527-31. PubMed ID: 24363993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2 activates augmenter of liver regeneration (ALR) via antioxidant response element and links oxidative stress to liver regeneration.
    Dayoub R; Vogel A; Schuett J; Lupke M; Spieker SM; Kettern N; Hildt E; Melter M; Weiss TS
    Mol Med; 2013 Aug; 19(1):237-44. PubMed ID: 23887691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
    Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S
    Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis.
    Köhler UA; Kurinna S; Schwitter D; Marti A; Schäfer M; Hellerbrand C; Speicher T; Werner S
    Hepatology; 2014 Aug; 60(2):670-8. PubMed ID: 24310875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.